Severe obesity: Evidence for a deranged metabolic program in skeletal muscle?

Exercise and Sport Sciences Reviews

Volumn 40, Issue 4, 2012, Pages 204-210

  Houmard, Joseph A ^a,b   Pories, Walter J ^b   Dohm, G Lynis ^b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

bariatric surgery; Class III obesity; exercise training; fat oxidation; insulin action; mitochondria; obesity

Indexed keywords

ANIMAL; ARTICLE; FAT INTAKE; HUMAN; LIPID METABOLISM; METABOLISM; MORBID OBESITY; PATHOLOGY; SKELETAL MUSCLE; TISSUE CULTURE TECHNIQUE; WEIGHT REDUCTION;

ANIMALS; DIETARY FATS; HUMANS; LIPID METABOLISM; MUSCLE, SKELETAL; OBESITY, MORBID; TISSUE CULTURE TECHNIQUES; WEIGHT LOSS;

EID: 84866943696     PISSN: 00916331     EISSN: None     Source Type: Journal    
DOI: 10.1097/JES.0b013e31825d53fc     Document Type: Article

References (35)

1. Azevedo JL Jr, Carey JO, Pories WJ, Morris PG, Dohm GL. Hypoxia stimulates glucose transport in insulin-resistant human skeletal muscle. Diabetes. 1995; 44:695-8.
2. Bell JA, Reed MA, Consitt LA, et al. Lipid partitioning, incomplete fatty acid oxidation, and insulin signal transduction in primary human muscle cells: Effects of severe obesity, fatty acid incubation, and fatty acid translocase/CD36 overexpression. J. Clin. Endocrinol. Metab. 2010; 95: 3400-10.
3. Berggren JR, Boyle KE, Chapman WH, Houmard JA. Skeletal muscle lipid oxidation and obesity: Influence of weight loss and exercise. Am. J. Physiol. Endocrinol. Metab. 2008; 294:E726-32.
4. Bikman BT, Zheng D, Pories WJ, et al. Mechanism for improved insulin sensitivity after gastric bypass surgery. J. Clin. Endocrinol. Metab. 2008; 93:4656-63.
5. Bikman BT, Zheng D, Reed MA, Hickner RC, Houmard JA, Dohm GL. Lipid-induced insulin resistance is prevented in lean and obese myotubes by AICAR treatment. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010; 298:R1692-9.
6. Boyle KE, Canham JP, Consitt LA, et al. A high-fat diet elicits differential responses in genes coordinating oxidative metabolism in skeletal muscle of lean and obese individuals. J. Clin. Endocrinol. Metab. 2011; 96:775-81.
7. Boyle KE, Zheng D, Anderson EJ, Neufer PD, Houmard JA. Mitochondrial lipid oxidation is impaired in cultured myotubes from obese humans. Int. J. Obes. (Lond). 2012; 36:1025-31.
8. Brozinick JT Jr, Roberts BR, Dohm GL. Defective signaling through Akt- 2 and -3 but not Akt-1 in insulin-resistant human skeletal muscle: Potential role in insulin resistance. Diabetes. 2003; 52:935-41.
9. Carey JO, Azevedo JL Jr, Morris PG, Pories WJ, Dohm GL. Okadaic acid, vanadate, and phenylarsine oxide stimulate 2-deoxyglucose transport in insulin-resistant human skeletal muscle. Diabetes. 1995; 44:682-8.
10. Caro JF, Sinha MK, Raju SM, et al. Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes. J. Clin. Invest. 1987; 79:1330-7.
11. Consitt LA, Bell JA, Koves TR, et al. Peroxisome proliferatorYactivated receptorYgamma coactivator-1alpha overexpression increases lipid oxidation in myocytes from extremely obese individuals. Diabetes. 2010; 59:1407-15.
12. Cortright RN, Azevedo JL Jr, Zhou Q, et al. Protein kinase C modulates insulin action in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2000; 278:E553-62.
13. Dohm GL, Elton CW, Raju MS, et al. IGF-IYstimulated glucose transport in human skeletal muscle and IGF-I resistance in obesity and NIDDM. Diabetes. 1990; 39:1028-32.
14. Dohm GL, Tapscott EB, Pories WJ, et al. An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects. J. Clin. Invest. 1988; 82:486-94.
15. Dolan PL, Tapscott EB, Dorton PJ, Dohm GL. Contractile activity restores insulin responsiveness in skeletal muscle of obese Zucker rats. Biochem. J. 1993; 289(pt 2):423-6.
16. Elton CW, Tapscott EB, Pories WJ, Dohm GL. Effect of moderate obesity on glucose transport in human muscle.Horm. Metab. Res. 1994; 26:181-3.
17. Friedman JE, Caro JF, Pories WJ, Azevedo JL Jr, Dohm GL. Glucose metabolism in incubated human muscle: Effect of obesity and noninsulin- dependent diabetes mellitus. Metabolism. 1994; 43:1047-54.
18. Friedman JE, Dohm GL, Leggett-Frazier N, et al. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J. Clin. Invest. 1992; 89:701-5.
19. Goodyear LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, Dohm GL. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J. Clin. Invest. 1995; 95:2195-204.
20. Gray RE, Tanner CJ, Pories WJ, MacDonald KG, Houmard JA. Effect of weight loss on muscle lipid content in morbidly obese subjects. Am. J. Physiol. Endocrinol. Metab. 2003; 284:E726-32.
21. Guesbeck NR, Hickey MS, MacDonald KG, et al. Substrate utilization during exercise in formerly morbidly obese women. J. Appl. Physiol. 2001; 90:1007-12.
22. Hickey MS, Carey JO, Azevedo JL, et al. Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am. J. Physiol. 1995; 268:E453-7.
23. Hickey MS, Gavingan KE, McCammon MR, et al. Effects of 7 days of exercise training on insulin action in morbidly obese men. Clin. Exerc. Physiol. 1999; 1:24-8.
24. Hittel DS, Hathout Y, Hoffman EP, Houmard JA. Proteome analysis of skeletal muscle from obese and morbidly obese women. Diabetes. 2005; 54:1283-8.
25. Houmard JA, Tanner CJ, Yu C, et al. Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes. 2002; 51:2959-63.
26. Hulver MW, Berggren JR, Carper MJ, et al. Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. Cell Metab. 2005; 2:251-61.
27. Hulver MW, Berggren JR, Cortright RN, et al. Skeletal muscle lipid metabolism with obesity. Am. J. Physiol. Endocrinol. Metab. 2003; 284: E741-7.
28. Itani SI, Zhou Q, Pories WJ, MacDonald KG, Dohm GL. Involvement of protein kinase C in human skeletal muscle insulin resistance and obesity. Diabetes. 2000; 49:1353-8.
29. Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 2000; 279:E1039-44.
30. Park JJ, Berggren JR, Hulver MW, Houmard JA, Hoffman EP. GRB14, GPD1, and GDF8 as potential network collaborators in weight lossY induced improvements in insulin action in human skeletal muscle. Physiol. Genomics. 2006; 27:114-21.
31. Pender C, Goldfine ID, Tanner CJ, et al. Muscle insulin receptor concentrations in obese patients post bariatric surgery: Relationship to hyperinsulinemia. Int. J. Obes. Relat. Metab. Disord. 2004; 28:363-9.
32. Reed MA, Pories WJ, Chapman W, et al. Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes. J. Clin. Endocrinol. Metab. 2011; 96:2525-31.
33. Tanner CJ, Barakat HA, Dohm GL, et al. Muscle fiber type is associated with obesity and weight loss. Am. J. Physiol. Endocrinol. Metab. 2002; 282:E1191-6.
34. Thyfault JP, Kraus RM, Hickner RC, Howell AW, Wolfe RR, Dohm GL. Impaired plasma fatty acid oxidation in extremely obese women. Am. J. Physiol. Endocrinol. Metab. 2004; 287:E1076-81.
35. Zhou Q, Dolan PL, Dohm GL. Dephosphorylation increases insulinstimulated receptor kinase activity in skeletal muscle of obese Zucker rats. Mol. Cell. Biochem. 1999; 194:209-16.